The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

by Shamaila Munir Ahmad, Evelina Martinenaite, Morten Holmström, Mia Aaboe Jørgensen, Özcan Met, Claudia Nastasi, Uffe Klausen, Marco Donia, Lars Møller Pedersen, Lars Munksgaard, Niels Ødum, Anders Woetmann, Inge Marie Svane, Mads Hald Andersen
Published 2018-02-01

444 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination

by Vincent Ho, Nina Bhardwaj, Timothy Chan, Joseph Park, Stephane Pourpe, Arnab Ghosh, Cansu Cimen Bozkus, Svena Verma, William Duke, Max Jan, Matthew Leventhal, Gabriela Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Hasselbalch, Jacob Grauslund, Mads Andersen, Morten Holmström, Raajit Rampal, Omar Abdel-Wahab, Ann Mullally
Published 2020-11-01